Provention Bio, Inc. (PRVB) has 58 open-market insider trades by 12 insiders since 2018. The most active filer is Anthony Digiandomenico, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Sessa Capital IM GP, LLC | 10% Owner | — | 1 | $106.5M | 2023-04-27 |
| Sessa Capital (Master), L.P. | 10% Owner | — | 1 | $28.2M | 2023-04-04 |
| Francisco Leon | CSO | — | 14 | $3.4M | 2023-04-27 |
| Peter A. Appel | 10% Owner | — | 1 | $3.0M | 2018-07-19 |
| Ashleigh Palmer | CEODir | — | 11 | $1.4M | 2023-04-27 |
| Anthony Digiandomenico | Dir | — | 16 | $1.3M | 2019-12-03 |
| Eleanor Ramos | COO | — | 5 | $339K | 2023-04-27 |
| Jeffrey Bluestone | Dir | — | 1 | $87K | 2020-04-10 |
| Andrew T. Drechsler | CFO | — | 3 | $71K | 2020-09-02 |
| Avery W. Catlin | Dir | — | 2 | $50K | 2023-04-27 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Sessa Capital IM GP, LLC | 10% Owner | Sell | $106.5M | 2023-04-14 |
| Francisco Leon | CSO | Sell | $1.0M | 2023-02-10 |
| Ashleigh Palmer | CEO & Director | Sell | $1.0M | 2023-02-10 |
| Jason Hoitt | Chief Commercial Officer | Sell | $45K | 2023-02-10 |
| Sessa Capital (Master), L.P. | 10% Owner | Sell | $28.2M | 2023-01-18 |
| Francisco Leon | CSO | Sell | $493K |
Companies that share insiders with PRVB, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2023-01-18 |
| Ashleigh Palmer | CEO & Director | Sell | $496K | 2023-01-18 |
| Francisco Leon | CSO | Sell | $1.9M | 2022-12-29 |
| Francisco Leon | CSO | Sell | $107K | 2022-12-27 |
| Francisco Leon | Chief Scientific Officer | Sell | $19K | 2022-12-22 |
| Eleanor Ramos | Chief Medical Officer | Buy | $34K | 2021-12-03 |
| Ashleigh Palmer | Director | Buy | $25K | 2021-11-30 |
| Francisco Leon | Chief Scientific Officer | Buy | $40K | 2021-11-24 |
| Eleanor Ramos | Chief Medical Officer | Buy | $4K | 2020-09-02 |
| Andrew T. Drechsler | CFO | Buy | $23K | 2020-09-02 |